Introducing NNIT Singapore

Following the acquisition of HGP in April 2019 and due legal processes, HGP’s Asia branch recently became NNIT Singapore Pte Ltd.

The Singapore Team has been supporting global pharmaceutical manufacturing companies in Singapore and surrounding territories since 2011. They will continue to do so as part of the NNIT Group, adding the strength and breadth of the Group to its selling proposition towards life sciences customers.

Director Wee Ming Chua elaborates:

“Working across the value chain, in lab environments, clinical operations, regulatory affairs, manufacturing and supply chain - from design to implementation, validation to operations – we bring people and technology together, create value and deliver solutions enabling our customers to deliver vital medical products to the market.”

27 NNIT employees operate out of the Singapore office, a beautifully preserved pre-wartime colonial shophouse, nestled within a conservation area amongst the skyscrapers so characteristic of Singapore’s bustling Central Business District.

The NNIT Group is growing both organically and via M&A. Eligible acquisitions within the business segment life sciences, in NNIT’s main markets Europe, Asia and the USA, is a particular focus.